Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 127

Results For "MEA"

1296 News Found

Biotech-PRIDE guidelines released
Biotech | August 05, 2021

Biotech-PRIDE guidelines released

Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.


Solara Active Pharma Science clocks net profit of Rs 50.13 crore in Q1FY22
News | August 04, 2021

Solara Active Pharma Science clocks net profit of Rs 50.13 crore in Q1FY22

Aditya Puri former MD of HDFC bank joins Solara board as chairman


Mindpeers launches on-demand behavioural healthcare platform
Healthcare | August 04, 2021

Mindpeers launches on-demand behavioural healthcare platform

It is designed to tackle mental health issues


Meddo acquires Doxper in a cash and stock deal
Healthcare | August 03, 2021

Meddo acquires Doxper in a cash and stock deal

This deal makes Meddo, one of the largest health-tech players in India


Drug exports grow on the back of govt support
Policy | August 03, 2021

Drug exports grow on the back of govt support

Drug formulations and biologics make impressive gains


Celanese opens  drug delivery feasibility lab at Florence, Kentucky site
News | July 21, 2021

Celanese opens drug delivery feasibility lab at Florence, Kentucky site

State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides


'We plan to invest Rs. 1,000 Cr in the next 3 to 4 years.' Priyanka Chigurupati, Executive Director, Granules Pharmaceutical Inc.
Interviews | June 10, 2021

'We plan to invest Rs. 1,000 Cr in the next 3 to 4 years.' Priyanka Chigurupati, Executive Director, Granules Pharmaceutical Inc.

In an exclusive interview with Rahul Koul of Indian Chemical News, Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals Inc. USA shared details about the company's performance, R&D initiatives, Capex plan, CSR, and future outlook. Excerpts of the interview:


Glenmark's interim data from PMS Study on Favipiravir released
News | June 09, 2021

Glenmark's interim data from PMS Study on Favipiravir released

The study was conducted in patients with mild to moderate COVID-19


New gen pharma leaders gear up to adopt digitalization, data analytics and customized R&D
Digitisation | May 27, 2021

New gen pharma leaders gear up to adopt digitalization, data analytics and customized R&D

The roller coaster ride during the pandemic has taken Indian pharmaceutical industry through a lot of bitter sweet experiences.


Pfizer registers Q4FY21net profit at Rs 100 Cr
News | May 26, 2021

Pfizer registers Q4FY21net profit at Rs 100 Cr

Revenue from operations for the year ended March 31, 2021 is ?2,239 crore